Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program.
about
State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and ImmunizationEligibility of persons who inject drugs for treatment of hepatitis C virus infection.Sample size determinations for group-based randomized clinical trials with different levels of data hierarchy between experimental and control arms.Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs.Profiting and providing less care: comprehensive services at for-profit, nonprofit, and public opioid treatment programs in the United StatesThe common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perceptionEvidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum.Primary Care-Based Hepatitis C Treatment Outcomes With First-Generation Direct-Acting Agents.Human immunodeficiency virus and liver disease: An update."Hepatitis C treatment turned me around:" Psychological and behavioral transformation related to hepatitis C treatment.Successful treatment of chronic hepatitis C with triple therapy in an opioid agonist treatment program.Public health clinic-based hepatitis C testing and linkage to care in Baltimore.2013 Update in addiction medicine for the generalist.Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all.Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection.Retention in buprenorphine treatment is associated with improved HCV care outcomes.Substance use, health status and service utilisation of older clients attending specialist drug and alcohol services.Recommendations for the management of hepatitis C virus infection among people who inject drugs.Expanding capacity for hepatitis C treatment in the United States: team-based care and use of nonphysician providers.Perceived benefits of the hepatitis C peer educators: a qualitative investigation.Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study.Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy.Reducing barriers to hepatitis C treatment among drug users: an integrated hepatitis C peer education and support program.The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs.
P2860
Q28079102-5928FC4D-8A8F-4112-B9CF-38E6A605417BQ30429470-4DE8D04A-B27D-4780-AB34-0DAF4458C1A9Q30842932-73085C4C-3E95-4C2C-9FC0-4DAE51CF2CBEQ31168171-95D342E6-0BF0-4C44-91D9-C9DC29FA694FQ34778712-BC9D4619-17C1-46DC-96A8-B4394B9B7D30Q35770129-4D5E9B11-AAD1-4852-A5AB-0CD3D278D0E4Q36079814-A43B858D-D455-4282-A5AD-B437A0300707Q36353382-DE859DD3-0C56-427F-BF82-E9C4796CAFB9Q36378109-0EC00FCE-07F3-4A76-9D1D-1DE0E931E72FQ36595767-F6F66E61-83EA-4A6C-9D75-9F34F2208F41Q36802839-3FDE518F-D672-47EE-8998-035ED3976B1DQ36813466-621FA4DD-A2B8-4988-9A91-9908D951106EQ37284626-E0111213-1C17-4E7B-BED6-2A0A660E87EDQ38123945-6E5F1A10-249F-4996-B328-60808AC8D8E8Q38123947-E89DF37F-47D4-4242-ABDF-98F1C0C7ADCDQ40317993-0DC87699-9D7E-4BD0-B2DD-D72D3325EFF8Q40395867-066F85C4-E4E5-4344-B189-9AFA91BAEA1FQ41047662-77338052-37A6-4C38-9BC6-8891CF91FFEDQ41412724-0BC53A5F-2D04-4B9A-8D46-89B4A286E6FAQ41942103-B0C979DB-26EC-4AF4-80F2-42B652811E58Q42251464-F7FC0324-9EFE-4B99-BB56-814B440E11D8Q49823266-8A1B848B-CF42-46E7-A64F-E7C1DAB3C020Q51831518-E291D098-B5F7-4916-8723-71B1C1E606CCQ52631124-F7051F77-E971-4C48-95E9-31FEEE0E6AE7
P2860
Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Concurrent group treatment for ...... maintenance treatment program.
@ast
Concurrent group treatment for ...... maintenance treatment program.
@en
type
label
Concurrent group treatment for ...... maintenance treatment program.
@ast
Concurrent group treatment for ...... maintenance treatment program.
@en
prefLabel
Concurrent group treatment for ...... maintenance treatment program.
@ast
Concurrent group treatment for ...... maintenance treatment program.
@en
P2093
P2860
P1476
Concurrent group treatment for ...... maintenance treatment program.
@en
P2093
Alain H Litwin
Irene J Soloway
Julia H Arnsten
Karen S Jefferson
Melissa R Stein
Robert J Roose
P2860
P304
P356
10.1016/J.JSAT.2012.08.007
P577
2012-10-02T00:00:00Z